Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

Nephrocare Health Services Financial Results

Nephrocare Health Services approved its FY26 audited financial results and authorized up to Rs. 10 Crore investment in its Nepal subsidiary. The board also approved credit security support.

Source

BSE filing, NSE: NEPHROPLUS. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Nephrocare Health Services Ltd: key numbers

Share price
₹628.40
Market cap
₹6,305 Cr
Revenue (annual)
₹998.8 Cr
Net profit (annual)
₹76.84 Cr
P/E (TTM)
74.1×Sector 52.0×
Promoter holding
58.31%-5.54% QoQ
FII holding
11.73%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Nephrocare Health Services Ltd

All →

Other financial results announcements

All →